NAD+ IV Infusion

High-dose NAD+ administered intravenously to restore cellular energy metabolism, support DNA repair mechanisms, and promote biological age reduction. Protocols are tailored to individual baseline NAD+ levels and health objectives.

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme central to mitochondrial energy production and a key activator of sirtuins — proteins intimately linked to cellular longevity and DNA repair. By the time most adults reach their forties, circulating NAD+ levels have declined by as much as 50%, contributing to diminished energy, slower cellular repair, and accelerating biological ageing. Intravenous NAD+ delivery bypasses gastrointestinal absorption limitations and rapidly elevates intracellular concentrations, producing effects that oral supplementation cannot reliably replicate. At Lifespan Asia, NAD+ infusion protocols are designed around each client's current health status, biological age markers, and longevity goals. A standard session delivers between 500 mg and 1,000 mg of pharmaceutical-grade NAD+ over two to three hours, with the infusion rate adjusted to ensure tolerability. Many clients report enhanced mental clarity, reduced fatigue, and improved sleep quality within days of treatment. NAD+ therapy is particularly valued for its role in activating PARP enzymes responsible for repairing DNA strand breaks — a mechanism directly relevant to cancer prevention and slowing epigenetic ageing. It also supports the function of AMPK, a master regulator of cellular metabolism that declines with age. For clients undergoing parallel interventions such as hyperbaric oxygen therapy or peptide protocols, NAD+ infusions act as a synergistic amplifier, enhancing mitochondrial response to these therapies. Lifespan Asia's clinical team monitors each client's response and can incorporate pre- and post-infusion biomarker assessments to document measurable improvements in metabolic function. Courses of four to ten sessions are commonly recommended for sustained biological benefit, with maintenance infusions scheduled monthly or quarterly thereafter.